SikanderAilawadhiMD

PubMed

• Comparative effectiveness of lenalidomide/dexamethasone-based triplet regimens for treatment of relapsed and/or refractory multiple myeloma in the United States: An an...
  Mu Cheng, Dasha Cherepanov, Maral DerSarkissian, Dawn Marie Stull, Annalise Hilts, Justin Chun, Mei Sheng Duh, Larysa Sanchez, Sikander Ailawadhi> ;Current Problems in Cancer. 2024 Mar 27
• Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens:...
  Michel Delforge, Krina Patel, Laurie Eliason, Devender Dhanda, Ling Shi, Shien Guo, Thomas S Marshall, Bertrand Arnulf, Michele Cavo, Ajay Nooka, Salomon Manier, Natal...> ;The Lancet. Haematology. 2024 Mar 1
• Management of Adverse Events Associated with Pomalidomide-Based Combinations in Patients with Relapsed/Refractory Multiple Myeloma.
  Omar Nadeem, Sikander Ailawadhi, Jack Khouri, Louis Williams, Donna Catamero, Kathryn Maples, Jesús Berdeja> ;Cancers. 2024 Feb 29
• Recent Developments in Convenience of Administration of the Anti-CD38 Antibody Isatuximab: Subcutaneous Delivery and Fast Intravenous Infusion in Patients With Multipl...
  Hang Quach, Gurdeep Parmar, Maria-Victoria Mateos, Xavier Leleu, Sikander Ailawadhi> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Feb 12
• Assessment of second primary malignancies among treated and untreated patients with chronic lymphocytic leukemia using real-world data from the USA.
  Ravelo, A., Ng, C., Shah, B., Lamarre, N., Wang, R., Eakle, K., Biondo, J., Ailawadhi, S.> ;Journal of Comparative Effectiveness Research. 2024 Feb 1
• Optimizing the CAR T-Cell Therapy Experience in Multiple Myeloma: Clinical Pearls From an Expert Roundtable.
  Shune, L., Ailawadhi, S., Wong, S., Lin, Y., Patel, K., Jagannath, S.> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Feb 1
• A phase II study of ibrutinib in combination with ixazomib in patients with Waldenström macroglobulinaemia.
  Parrondo, R., Dutta, N., LaPlant, B., Elliott, J., Fernandez, A., Zimmerman, A., Cicco, G., Han, B., Heslop, K., Chapin, D., Sher, T., Roy, V., Rasheed, A., Das, S., C...> ;British Journal of Haematology. 2024 Jan 29
• 1 citations
  Development and validation of algorithms for identifying lines of therapy in multiple myeloma using real-world data.
  Sikander Ailawadhi, Dorothy Romanus, Surbhi Shah, Kathy Fraeman, Delphine Saragoussi, Rebecca Morris Buus, Binh Nguyen, Dasha Cherepanov, Lois Lamerato, Ariel Berger> ;Future Oncology. 2024 May 1
• An Open-Label Phase I Study of Metformin and Nelfinavir in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma.
  Alodhaibi, I., Burbano, G., O'Brien, P., Ailawadhi, S., Buadi, F., Hayman, S., Kumar, S., Gonsalves, W.> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Jan 6
• 1 citations
  Superior detection rate of plasma cell FISH using FACS-FISH.
  Gagnon, M., Midthun, S., Fangel, J., Schuh, C., Luoma, I., Pearce, K., Meyer, R., Ailawadhi, S., Arribas, M., Braggio, E., Fonseca, R., Rajkumar, S., Zepeda-Mendoza, C...> ;American Journal of Clinical Pathology. 2024 Jan 4
• MicroRNA and long non-coding RNA analysis in IgM monoclonal gammopathies reveals epigenetic influence on cellular functions and oncogenesis.
  Karan Chohan, Jonas Paludo, Surendra Dasari, Patrizia Mondello, Joseph P Novak, Jithma P Abeykoon, Kerstin Wenzl, Zhi-Zhang Yang, Shahrzad Jalali, Jordan E Krull, Este...> ;Haematologica. 2023 Dec 7
• Clinical trial design change implementation for inclusive studies.
  Manuel R Espinoza-Gutarra, Jack Aiello, Robert Z Orlowski, Sikander Ailawadhi> ;The Lancet. Haematology. 2023 Dec 1
• Real-World Utilization of Radiation Therapy in Multiple Myeloma: An Analysis of the Connect MM Registry.
  Leslie Ballas, Sikander Ailawadhi, Mohit Narang, Cristina J Gasparetto, Hans C Lee, James W Hardin, Brian G M Durie, Kathleen Toomey, James Omel, Lynne I Wagner, Rafat...> ;Practical Radiation Oncology. 2023 Nov 19
• Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Prelim...
  Saurav Das, Sikander Ailawadhi, Taimur Sher, Vivek Roy, Andre Fernandez, Ricardo D Parrondo> ;Current Oncology. 2023 Oct 31
• Acute esophageal stricture after bone marrow transplant.
  Songhan Pang, Hasan Saleh, Sikander Ailawadhi, Mark Edgar, Maoyin Pang> ;Clinical Journal of Gastroenterology. 2024 Feb 1
• Bridging the gap: how do we enroll more racial-ethnic minority patients in hematological drug trials?
  Manuel R Espinoza-Gutarra, Sikander Ailawadhi> ;Expert Review of Hematology. 2023 Dec 18
• Comparison of health care costs and resource utilization for commonly used proteasome inhibitor-immunomodulatory drug-based triplet regimens for the management of pati...
  Larysa Sanchez, Ajai Chari, Mu Cheng, Dasha Cherepanov, Maral DerSarkissian, Fei Huang, Dawn Marie Stull, Jonathan Dabora, Melanie Young, Stephen J Noga, Selina Pi, Me...> ;Journal of Managed Care & Specialty Pharmacy. 2023 Nov 1
• The digital divide: Racial disparities in adoption and utilization of health information technology among patients with lymphoid cancers.
  Sikander Ailawadhi, Meghna Ailawadhi, Navnita Dutta, Ricardo D Parrondo, Vivek Roy, Taimur Sher, Mizba Baksh, Ahsan Rasheed, Saurav Das, Andre J Fernandez, Aneel Paulu...> ;Cancer Medicine. 2023 Sep 1
• 19 citations
  The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma.
  Kai Rejeski, Doris K Hansen, Radhika Bansal, Pierre Sesques, Sikander Ailawadhi, Jennifer M Logue, Eva Bräunlein, David M Cordas Dos Santos, Ciara L Freeman, Melissa A...> ;Journal of Hematology & Oncology. 2023 Jul 31
• 2 citations
  Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.
  Udit Yadav, Shaji K Kumar, Linda B Baughn, Angela Dispenzieri, Patricia Greipp, Rhett Ketterling, Dragan Jevremovic, Francis K Buadi, David Dingli, Martha Q Lacy, Rafa...> ;Blood. 2023 Nov 30
• Trends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation...
  Farah Yassine, Mohamed A Kharfan-Dabaja, Athanasios Tsalantsanis, Vivek Roy, Abba C Zubair, Hemant S Murthy, Ernesto Ayala, Madiha Iqbal, Taimur Sher, Sikander Ailawad...> ;Bone Marrow Transplantation. 2023 Oct 1
• Multiple Myeloma: Current Clinical Landscape and Compounding Costs.
  Kelsey Beck, Tyler Sandahl, Sikander Ailawadhi, Nandita Khera, Chelsee Jensen> ;Current Hematologic Malignancy Reports. 2023 Oct 1
• 2 citations
  Global disparities in patients with multiple myeloma: a rapid evidence assessment.
  Maria-Victoria Mateos, Sikander Ailawadhi, Luciano J Costa, Shakira J Grant, Lalit Kumar, Mohamad Mohty, Didem Aydin, Saad Z Usmani> ;Blood Cancer Journal. 2023 Jul 18
• 1 citations
  Post-Autologous Hematopoietic Cell Transplant Care in the "Home Sweet Home" Setting: A Treatment Paradigm Shift.
  Mohamed A Kharfan-Dabaja, Vivek Roy, Hemant Murthy, Deborah Fischer, Razan Mohty, Ashley Greathouse, Alethea Brown, Kathryn Moreno, Emily Godsey, Jennifer M Higginboth...> ;Hematology/oncology and Stem Cell Therapy. 2023 May 23
• 1 citations
  Partnering With All Patients: Ensuring Shared Decision Making and Evidence-Based Management for Underrepresented Groups With Multiple Myeloma.
  Claudio Cerchione, Shakira J Grant, Sikander Ailawadhi> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023 May 1
• Join now to see all

Journal Articles

• Targeting CD38 with Daratumumab Is Lethal to Waldenström Macroglobulinaemia Cells  
  Richard Furman, Stephen M Ansell, Sikander Ailawadhi, Thomas E Witzig, Vivek Roy, Taimur Sher, Liuyan Jiang, British Journal of Haematology
• Utilization of Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Myeloma: A Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consen...  
  John A Lust, Shaji K Kumar, Morie A Gertz, P Leif Bergsagel, Angela Dispenzieri, Francis K Buadi, Prashant Kapoor, Angela A Mayo, Wilson I Gonsalves, Rafael Fonseca, R..., Nature

Abstracts/Posters

• Economic Burden of Emergency Room (ER) Visits and Hospitalizations Among Newly Diagnosed Multiple Myeloma (NDMM) Patients in the United States
  Sikander Ailawadhi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Comparative Effectiveness of Triplets Containing Bortezomib (V), Carfilzomib (K), or Ixazomib (I) Combined with a Lenalidomide and Dexamethasone Backbone (Rd) in Patie...
  Sikander Ailawadhi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Phase I Study of a Novel Bcl-2 Inhibitor, at-101 in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)
  Sikander Ailawadhi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Sociodemographic and Clinical Characteristics Associated with PatientÍs Decision to Refuse Multiple Myeloma (MM) Treatment, and Its Impact on Outcomes
  Sikander Ailawadhi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Population-Based Analysis of Predictors of Survival and Trends in Outcomes of Elderly Patients with Multiple Myeloma (MM)
  Sikander Ailawadhi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Trends in Early Mortality from Multiple Myeloma (MM): A Population-Based Analysis
  Sikander Ailawadhi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Long Non-Coding RNA Expression in Waldenstrom Macroglobulinemia and IgM Monoclonal Gammopathy of Undetermined Significance
  Sikander Ailawadhi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Comprehensive Investigation of White Blood Cell and Gene Expression Profiles As Risk Factors for Multiple Myeloma in African Americans
  Sikander Ailawadhi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Phase 1 First-in-Human Study of the Anti-CD38 Dimeric Fusion Protein TAK-169 for the Treatment of Patients (pts) with Relapsed or Refractory Multiple Myeloma (RRMM) ...
  Sikander Ailawadhi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Clinical Outcomes and Health-Related Quality of Life (HRQoL) Among Randomized Clinical Trial (RCT)-Eligible and RCT-Ineligible Patients: Results from the Connect¬ MM R...
  Sikander Ailawadhi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Phase 1/2 Study to Assess Safety and Dose of Ixazomib in Combination with Cyclophosphamide and Dexamethasone in Newly Diagnosed Patients with Light Chain (AL) Amyloi...
  Sikander Ailawadhi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Treatment Patterns and Outcomes in Elderly Patients with Newly Diagnosed Multiple Myeloma: Results from the Connect¬ MM Registry
  Sikander Ailawadhi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Randomized Phase 2 Study Comparing Acalabrutinib with or without Obinutuzumab in the Treatment of Early Stage High Risk Patients with Chronic Lymphocytic Leukemia (C...
  Sikander Ailawadhi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Racial Disparities in Multiple Myeloma Care 
  ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
• Phase I Study of a Novel Bcl-2 Inhibitor, at-101 in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM) 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Evolving Real-World Treatment Patterns in Patients with Newly-Diagnosed Multiple Myeloma (NDMM) in the United States (U.S.) 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Comparative analysis of outcomes in African American (AA) and white (W) patients (pts) with multiple myeloma (MM) treated with lenalidomide (LEN) or pomalidomide (POM). 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• Low vs high dose carfilzomib (Cfz) with dexamethasone (Dex) for relapsed/refractory multiple myeloma (RRMM): Results of SWOG S1304. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• Join now to see all